InpharmD Analysis: $6M Raised
What is InpharmD?
InpharmD offers a platform for clinical pharmacists to conduct custom literature searches, providing curated responses to clinical questions to enhance patient care efficiency.
Employees
16
Founded
2018
Revenue
$2-5M
Product Features & Capabilities
- One touch literature search, custom literature search for clinical questions, actionable drug information in real time, tailored responses to clinical inquiries, 95,954 clinical pharmacist hours saved, 100% customer satisfaction rate.
Pricing
- Up to 30 seats: $500/seat/month
- 30 - 200 seats: $400/seat/month
- 200 - 1000 seats: $300/seat/month
- 1000+ seats: Pricing available upon inquiry
How much InpharmD raised
Seed - $6.05 million
December 9, 2023Lead Investor: Led by 645 Ventures
Who are the founders of InpharmD
AA
Ashish Advani
Founder
TR
Tulasee Rao Chintha
Founder
Investors
- 645 Ventures
- Atlanta Ventures
- Y Combinator
- Qlarant Capital
- SF ELC
Competitors Overview
InpharmD operates in the clinical pharmacy market, providing a platform for clinical pharmacists to conduct custom literature searches and obtain curated responses to clinical questions. Its main competitors include:
- WhizAI: Focuses on AI-driven insights for healthcare providers, helping the
Business Model
Charges per seat for users, aiming to convert health systems into customers for revenue.
Market Focus
InpharmD primarily focuses on the healthcare industry, specifically in the area of clinical pharmacy. They provide a platform that assists clinical pharmacists in conducting literature searches to enhance patient care.
See something that needs updating? Suggest edits to this profile.